Melanotan II vs Hexarelin
A comprehensive, data-driven comparison of Melanotan II (MT-2) and Hexarelin (Examorelin). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | Melanotan II MT-2, Melanotan 2 | Hexarelin Examorelin |
|---|---|---|
| FDA Status | Not submitted | Not submitted |
| Category | Sexual Health | Growth Hormone |
| Primary Use | Tanning and sexual dysfunction (research) | Growth hormone optimization and cardiac protection |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $30 - $60/mo | $40 - $80/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 0.25-1mg 2-3x per week | 100-200mcg 2x daily (pulsed use recommended) |
| Frequency | As needed | Daily |
| Mechanism | Melanocortin receptor agonist that stimulates melanogenesis for tanning and has effects on sexual arousal | Potent growth hormone secretagogue with cardioprotective properties beyond GH stimulation |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Low | Emerging |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Melanotan II is generally more affordable ($30 - $60/mo) compared to Hexarelin ($40 - $80/mo).
- 2Melanotan II is dosed as needed, while Hexarelin is daily.
- 3Melanotan II has low-quality evidence, while Hexarelin has emerging-quality evidence.
- 4They belong to different categories: Melanotan II (Sexual Health) vs Hexarelin (Growth Hormone).
Which Is Better For...
Melanotan II
More budget-friendly option with lower monthly costs
Melanotan II
More convenient dosing schedule (as needed)
Melanotan II
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| Melanotan II | $30 - $60/mo | Not submitted | Various research labs |
| Hexarelin | $40 - $80/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
Melanotan II works via Melanocortin receptor agonist that stimulates melanogenesis for tanning and has effects on. Hexarelin works via Potent growth hormone secretagogue with cardioprotective properties beyond GH stimulation. They differ in FDA approval status, efficacy data, and cost.
Melanotan II typically costs $30 - $60/mo, while Hexarelin costs $40 - $80/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
Melanotan II is not FDA-approved (Not submitted). Hexarelin is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of Melanotan II include Nausea, Flushing, Spontaneous erections. Common side effects of Hexarelin include Increased appetite, Cortisol elevation, Prolactin elevation. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
Melanotan II is a synthetic analog of alpha-melanocyte stimulating hormone that binds to melanocortin receptors. Originally developed for skin tanning protection against UV damage, it was found to hav...
View Full Melanotan II GuideHexarelin is a synthetic hexapeptide GH secretagogue that is significantly more potent than GHRP-6. Beyond stimulating growth hormone release, research has revealed unique cardioprotective effects ind...
View Full Hexarelin GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between Melanotan II and Hexarelin should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.